Overdiagnosis Archives - Page 2 of 6

Marketing empowerment: how corporations co-opt feminist narratives to promote non-evidence based health interventions – Copp et al.

Krista Verlis2024-02-16T10:55:01+11:00Overdiagnosis, Overtesting, Overtreatment, Publications, Women's health|

Promotion of non-evidence based tests and treatments using empowerment messages risks women being overdiagnosed and overtreated, argue Tessa Copp and colleagues. Commercial organisations have an extraordinary influence on population health through how they engage with and shape social movements to market their products.1 Corporations have historically exploited [...]

The Guardian – Companies marketing useless health products to women using feminist wellbeing messages

Krista Verlis2024-02-16T10:42:21+11:00News, Overdiagnosis, Overtreatment, Women's health|

Researchers find promotions encouraging women to take charge of their health could lead to overdiagnosis and unnecessary treatment. Corporations are co-opting feminist messages around women’s wellbeing to promote useless health tests and treatments, an analysis by Australian researchers has found. Published in the British Medical Journal [...]

Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method – Adewole S. Adamson et al.

Lucia Marcello2024-02-11T15:27:31+11:00Cancer, Melanoma, Overdiagnosis, Publications, Risk|

The objective of this study is to quantify the proportion of melanoma diagnoses (invasive and in situ) in the USA that might be overdiagnosed. In this ecological study, incidence and mortality data were collected from the Surveillance, Epidemiology and End Results 9 registries database. DevCan [...]

Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility – Patti Shih et al.

Lucia Marcello2024-02-11T14:15:02+11:00Genetic testing, Low-value care, Overdiagnosis, Overtesting, Overtreatment, Overuse, Publications|

The growing number of Direct To Consumer (DTC) tests available for direct purchase online in Australia purport to empower consumers with choice and convenience of access. The categorisation of clinical utility developed in this study shows the majority of currently available products lack clear benefits [...]

Gestational Diabetes and Cardiovascular Health – Katy J. L. Bell, Paul P. Glasziou & Jenny A. Doust

Lucia Marcello2024-02-11T14:11:39+11:00Cardiovascular disease, Gestational diabetes, Overdiagnosis, Overtreatment, Publications, Women's health|

To the Editor: Good clinical decisions should weigh benefits against harms. The recent JAMA Insights article on gestational diabetes mellitus (GDM) focused on the potential benefits of increased detection and treatment of GDM and subsequent promotion of cardiovascular health.1 Unmentioned were the potential detrimental effects of overdiagnosis [...]

The Conversation: You can now order all kinds of medical tests online. Our research shows this is (mostly) a bad idea

Lucia Marcello2024-02-16T10:48:52+11:00Low-value care, Media, News, Overdiagnosis, Overtesting|

Many of us have done countless rapid antigen tests (RATs) over the course of the pandemic. Testing ourselves at home has become second nature. But there’s also a growing worldwide market in medical tests sold online directly to the public. These are “direct-to-consumer” tests, and [...]

First do no harm in responding to incidental imaging findings – Ian A Scott, John Slavotinek &Paul P Glasziou

Lucia Marcello2023-12-04T14:34:57+11:00Cancer, Imaging, Low-value care, Overdiagnosis, Overtreatment, Publications, Screening|

You order a computed tomography pulmonary angiogram (CTPA) for a patient with suspected pulmonary thromboembolism. The radiology report states that no pulmonary thromboembolism is seen but notes an unrelated lung nodule. What should you do with this incidental finding, or “incidentaloma”?

Health benefits and harms of mammography screening in older women (75+ years)-a systematic review – Erin Mathieu et al.

Lucia Marcello2023-12-04T13:33:17+11:00Ageing, Breast cancer, Cancer, Overdiagnosis, Publications, Screening, Women's health|

There is little evidence on the balance between potential benefits and harms of mammography screening in women 75 years and older. The aim of this systematic review was to synthesise the evidence on the outcomes of mammography screening in women aged 75 years and older. [...]

Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study – Zachary Desson et al.

Lucia Marcello2024-04-05T14:31:16+11:00Cardiovascular disease, Diagnostic system, Hypertension, Low-value care, Overdiagnosis, Overtreatment, Publications, Underdiagnosis|

The VALID BP project was initiated to increase the availability of validated blood pressure measuring devices (BPMDs). The goal is to eliminate non validated BPMDs and minimise over- and underdiagnosis of hypertension caused by inaccurate readings. This study was undertaken to assess the potential return [...]

Evidence for overdiagnosis in non-cancer conditions was assessed: a metaepidemiological study using the ‘Fair Umpire’ framework – Sharon Sanders et al.

Lucia Marcello2023-12-04T12:23:07+11:00Diagnostic system, Overdiagnosis, Publications, Research, Tests|

The objective of this study is to evaluate the strength of the evidence for, and the extent of, overdiagnosis in non-cancer conditions. We systematically searched for studies investigating overdiagnosis in non-cancer conditions. Using the 'Fair Umpire' framework to assess the evidence that cases diagnosed by [...]

Overdiagnosis

Staff Intranet